Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	3'-phosphoadenosine 5'-phosphosulfate binding	SULT1C4 CHST15 GAL3ST3	1.10e-04	13	149	3	GO:0050656
GeneOntologyMolecularFunction	histone binding	IPO7 TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 SFMBT2 TSPY10	1.73e-04	265	149	9	GO:0042393
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DYNC2H1 DNAH1 DNAH8	3.06e-04	18	149	3	GO:0008569
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	3.29e-04	4	149	2	GO:0005219
GeneOntologyMolecularFunction	intracellularly calcium-gated channel activity	BEST1 ANO6 ANO3	4.23e-04	20	149	3	GO:0141147
GeneOntologyMolecularFunction	intracellularly calcium-gated chloride channel activity	BEST1 ANO6 ANO3	4.23e-04	20	149	3	GO:0005229
GeneOntologyBiologicalProcess	gonadal mesoderm development	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 TSPY10	3.32e-14	9	150	7	GO:0007506
GeneOntologyBiologicalProcess	mesoderm development	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 POGLUT1 TSPY10 FGFR1	2.27e-06	157	150	9	GO:0007498
GeneOntologyBiologicalProcess	nucleosome assembly	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 TSPY10	3.12e-05	122	150	7	GO:0006334
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH1 MDN1 DNAH8	3.02e-06	14	142	4	IPR011704
Domain	AAA_5	DYNC2H1 DNAH1 MDN1 DNAH8	3.02e-06	14	142	4	PF07728
Domain	NAP_family	TSPY4 TSPY2 TSPY8 TSPY10	7.06e-06	17	142	4	IPR002164
Domain	NAP	TSPY4 TSPY2 TSPY8 TSPY10	7.06e-06	17	142	4	PF00956
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH1 DNAH8	1.47e-04	14	142	3	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH1 DNAH8	1.47e-04	14	142	3	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH1 DNAH8	1.47e-04	14	142	3	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH1 DNAH8	1.47e-04	14	142	3	PF08393
Domain	MT	DYNC2H1 DNAH1 DNAH8	1.47e-04	14	142	3	PF12777
Domain	AAA_8	DYNC2H1 DNAH1 DNAH8	1.47e-04	14	142	3	PF12780
Domain	Ryanodine_rcpt	RYR2 RYR3	1.71e-04	3	142	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR2 RYR3	1.71e-04	3	142	2	IPR009460
Domain	RyR	RYR2 RYR3	1.71e-04	3	142	2	PF02026
Domain	RR_TM4-6	RYR2 RYR3	1.71e-04	3	142	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	1.71e-04	3	142	2	IPR013333
Domain	DHC_fam	DYNC2H1 DNAH1 DNAH8	1.83e-04	15	142	3	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH1 DNAH8	1.83e-04	15	142	3	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DNAH1 DNAH8	1.83e-04	15	142	3	IPR004273
Domain	FerI	OTOF FER1L5	5.65e-04	5	142	2	SM01202
Domain	FerB	OTOF FER1L5	5.65e-04	5	142	2	SM01201
Domain	Ferlin_B-domain	OTOF FER1L5	5.65e-04	5	142	2	IPR012561
Domain	Ferlin_C	OTOF FER1L5	5.65e-04	5	142	2	PF16165
Domain	Ferlin_C	OTOF FER1L5	5.65e-04	5	142	2	IPR032362
Domain	FerIin_dom	OTOF FER1L5	5.65e-04	5	142	2	IPR012968
Domain	FerI	OTOF FER1L5	5.65e-04	5	142	2	PF08151
Domain	FerB	OTOF FER1L5	5.65e-04	5	142	2	PF08150
Domain	RIH_assoc-dom	RYR2 RYR3	8.44e-04	6	142	2	IPR013662
Domain	Ins145_P3_rec	RYR2 RYR3	8.44e-04	6	142	2	PF08709
Domain	RIH_assoc	RYR2 RYR3	8.44e-04	6	142	2	PF08454
Domain	RIH_dom	RYR2 RYR3	8.44e-04	6	142	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	8.44e-04	6	142	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	8.44e-04	6	142	2	IPR015925
Domain	-	RYR2 RYR3	8.44e-04	6	142	2	1.25.10.30
Domain	RYDR_ITPR	RYR2 RYR3	8.44e-04	6	142	2	PF01365
Domain	PROTEIN_KINASE_TYR	TESK1 RYK FGFR1 PLK4 MUSK	8.71e-04	97	142	5	PS00109
Domain	Tyr_kinase_AS	TESK1 RYK FGFR1 PLK4 MUSK	8.71e-04	97	142	5	IPR008266
Domain	Anoct_dimer	ANO6 ANO3	1.18e-03	7	142	2	PF16178
Domain	Anoct_dimer	ANO6 ANO3	1.18e-03	7	142	2	IPR032394
Domain	DHC_N1	DYNC2H1 DNAH8	1.56e-03	8	142	2	PF08385
Domain	Carboxylesterase_B_AS	CES3 CES4A	1.56e-03	8	142	2	IPR019826
Domain	CARBOXYLESTERASE_B_1	CES3 CES4A	1.56e-03	8	142	2	PS00122
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH8	1.56e-03	8	142	2	IPR013594
Domain	SAM_1	CNKSR2 SFMBT2 SGMS1 USH1G	1.79e-03	68	142	4	PF00536
Domain	MIR	RYR2 RYR3	2.48e-03	10	142	2	PF02815
Domain	MIR_motif	RYR2 RYR3	2.48e-03	10	142	2	IPR016093
Domain	Anoctamin	ANO6 ANO3	2.48e-03	10	142	2	PF04547
Domain	Anoctamin	ANO6 ANO3	2.48e-03	10	142	2	IPR007632
Domain	MIR	RYR2 RYR3	2.48e-03	10	142	2	PS50919
Domain	MIR	RYR2 RYR3	2.48e-03	10	142	2	SM00472
Domain	Pkinase_Tyr	TESK1 RYK FGFR1 PLK4 MUSK	3.07e-03	129	142	5	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	TESK1 RYK FGFR1 PLK4 MUSK	4.09e-03	138	142	5	IPR001245
Domain	-	DYNC2H1 WRN SLFN5 PFKFB4 SULT1C4 DNAH1 MDN1 CHST15 GAL3ST3 DNAH8 HYDIN ELP4 AQR	4.56e-03	746	142	13	3.40.50.300
Domain	CARBOXYLESTERASE_B_2	CES3 CES4A	4.92e-03	14	142	2	PS00941
Domain	-	AOX1 MRPL39	4.92e-03	14	142	2	3.10.20.30
Domain	COesterase	CES3 CES4A	4.92e-03	14	142	2	PF00135
Domain	Beta-grasp_dom	AOX1 MRPL39	4.92e-03	14	142	2	IPR012675
Domain	CarbesteraseB	CES3 CES4A	4.92e-03	14	142	2	IPR002018
Domain	SAM_DOMAIN	CNKSR2 SFMBT2 SGMS1 USH1G	5.98e-03	95	142	4	PS50105
Domain	SAM	CNKSR2 SFMBT2 SGMS1 USH1G	6.43e-03	97	142	4	IPR001660
Domain	ConA-like_dom	CANX RYR2 RYR3 LMAN2L MAMDC2 WDFY3	6.63e-03	219	142	6	IPR013320
Domain	Gal_mutarotase_SF_dom	MAN2B1 MGAM2	7.24e-03	17	142	2	IPR011013
Domain	Poly(ADP-ribose)pol_cat_dom	PARP4 ZC3HAV1	7.24e-03	17	142	2	IPR012317
Domain	PARP_CATALYTIC	PARP4 ZC3HAV1	7.24e-03	17	142	2	PS51059
Domain	PARP	PARP4 ZC3HAV1	7.24e-03	17	142	2	PF00644
Domain	-	PARP4 ZC3HAV1	7.24e-03	17	142	2	3.90.228.10
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TRAF2 IPO7 DYNC2H1 ELOVL5 MRPS27 DCAF12L2 RYR2 USP6 PARP4 OSBP MDN1 USH1G WDFY3 FER1L5 WDR17 CNOT1 KNL1	3.74e-09	638	153	17	31182584
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FLII IPO7 WRN NBAS PARP4 MTOR DOCK7 CNOT1 TOP2B	3.05e-07	202	153	9	33005030
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-7 ERVK-10 ERVK-24	3.33e-07	4	153	3	10469592
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	SFXN4 OGT IPO7 KBTBD6 DYNC2H1 WRN UBA3 CNKSR2 NXN IWS1 MRPL39 USP6 DOCK7 MRPS34 CNOT1 VARS1 AQR LRRC15	5.07e-07	1005	153	18	19615732
Pubmed	Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.	TRAF2 PTPRC PRKCQ	8.29e-07	5	153	3	21282629
Pubmed	Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.	RYR2 RYR3 MUSK	1.65e-06	6	153	3	26025922
Pubmed	Immunohistochemical Expression Pattern of FGFR1, FGFR2, RIP5, and HIP2 in Developing and Postnatal Kidneys of Dab1-/- (yotari) Mice.	NPHS1 MTOR FGFR1	9.79e-06	10	153	3	35216141
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FLII TRAF2 IPO7 DYNC2H1 CANX MRPS27 RPS18 TESK1 MDN1 MTOR GLO1 DOCK7 MRPS34 CNOT1 VARS1 TOP2B AQR MGAM2 ZC3HAV1	1.73e-05	1425	153	19	30948266
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	HEATR4 CANX KBTBD7 RYK DIP2A CES4A DNAH8 MUSK ELP4 ZC3HAV1	1.84e-05	420	153	10	28065597
Pubmed	Nephrin missense mutations: induction of endoplasmic reticulum stress and cell surface rescue by reduction in chaperone interactions.	NPHS1 CANX	1.92e-05	2	153	2	24303155
Pubmed	[5-HT6 receptor-mTOR: An hyperactive couple in neuropathic pain].	HTR6 MTOR	1.92e-05	2	153	2	34003104
Pubmed	Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro.	CANX LPA	1.92e-05	2	153	2	9717723
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	1.92e-05	2	153	2	8898078
Pubmed	An Exceptional Gene: Evolution of the TSPY Gene Family in Humans and Other Great Apes.	TSPY9 TSPY1	1.92e-05	2	153	2	24710137
Pubmed	Structure and function of TSPY, the Y-chromosome gene coding for the "testis-specific protein".	TSPY9 TSPY1	1.92e-05	2	153	2	9678360
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	1.92e-05	2	153	2	14550562
Pubmed	A novel mechanism of thrombocytopenia by PS exposure through TMEM16F in sphingomyelin synthase 1 deficiency.	SGMS1 ANO6	1.92e-05	2	153	2	34478523
Pubmed	Apolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formation.	CANX LPA	1.92e-05	2	153	2	12562843
Pubmed	TSPY-related sequences represent a microheterogeneous gene family organized as constitutive elements in DYZ5 tandem repeat units on the human Y chromosome.	TSPY9 TSPY1	1.92e-05	2	153	2	8244388
Pubmed	Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells.	FKRP CANX	1.92e-05	2	153	2	15574464
Pubmed	mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.	MTOR FGFR1	1.92e-05	2	153	2	24925055
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	1.92e-05	2	153	2	21531043
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	1.92e-05	2	153	2	16678258
Pubmed	Battle of the sexes: contrasting roles of testis-specific protein Y-encoded (TSPY) and TSPX in human oncogenesis.	TSPY9 TSPY1	1.92e-05	2	153	2	29974883
Pubmed	Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway.	CANX LPA	1.92e-05	2	153	2	9925657
Pubmed	TSPY, the candidate gonadoblastoma gene on the human Y chromosome, has a widely expressed homologue on the X - implications for Y chromosome evolution.	TSPY9 TSPY1	1.92e-05	2	153	2	15241014
Pubmed	Decreased expression of ryanodine receptors alters calcium-induced calcium release mechanism in mdx duodenal myocytes.	RYR2 RYR3	1.92e-05	2	153	2	14985349
Pubmed	5-HT6 Receptor Recruitment of mTOR Modulates Seizure Activity in Epilepsy.	HTR6 MTOR	1.92e-05	2	153	2	25034463
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DYNC2H1 DNAH1 DNAH8	2.93e-05	14	153	3	9373155
Pubmed	Mapping the Genetic Landscape of Human Cells.	MRPS27 MRPL13 RPS18 UBA3 COQ2 MRPL39 MED24 MTOR CNOT1 ELP4	3.36e-05	451	153	10	30033366
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	IPO7 ZCCHC8 IWS1 LMAN2L PRDM12 CNOT1 HYDIN TOP2B AQR LRRC15	4.66e-05	469	153	10	27634302
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR2 RYR3	5.75e-05	3	153	2	18403125
Pubmed	FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.	MTOR FGFR1	5.75e-05	3	153	2	31371343
Pubmed	Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.	RYR2 RYR3	5.75e-05	3	153	2	29730765
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR2 RYR3	5.75e-05	3	153	2	7876312
Pubmed	Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia.	LPA SERPINE1	5.75e-05	3	153	2	12702502
Pubmed	The role of the fibrinolytic system in corneal angiogenesis.	LPA SERPINE1	5.75e-05	3	153	2	15166500
Pubmed	Genetic background determines response to hemostasis and thrombosis.	LPA SERPINE1	5.75e-05	3	153	2	17022820
Pubmed	Palmitate induced insulin resistance by PKCtheta-dependent activation of mTOR/S6K pathway in C2C12 myotubes.	MTOR PRKCQ	5.75e-05	3	153	2	20429048
Pubmed	Shigella Effector OspB Activates mTORC1 in a Manner That Depends on IQGAP1 and Promotes Cell Proliferation.	OSBP MTOR	5.75e-05	3	153	2	26473364
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR2 RYR3	5.75e-05	3	153	2	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR2 RYR3	5.75e-05	3	153	2	10788707
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR2 RYR3	5.75e-05	3	153	2	7621815
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR2 RYR3	5.75e-05	3	153	2	10473538
Pubmed	The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment.	KBTBD6 KBTBD7	5.75e-05	3	153	2	32572597
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR2 RYR3	5.75e-05	3	153	2	18434746
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR2 RYR3	5.75e-05	3	153	2	9204703
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR2 RYR3	5.75e-05	3	153	2	21881589
Pubmed	FGFR antagonist induces protective autophagy in FGFR1-amplified breast cancer cell.	MTOR FGFR1	5.75e-05	3	153	2	26993162
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR2 RYR3	5.75e-05	3	153	2	12213830
Pubmed	Identification of endogenous retroviral reading frames in the human genome.	ERVK-10 ERVFRD-1	5.75e-05	3	153	2	15476554
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR2 RYR3	5.75e-05	3	153	2	9242641
Pubmed	RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle.	RYR2 RYR3	5.75e-05	3	153	2	15024040
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR2 RYR3	5.75e-05	3	153	2	25239916
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR2 RYR3	5.75e-05	3	153	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR2 RYR3	5.75e-05	3	153	2	11159936
Pubmed	Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3.	SLC22A13 DLEC1	5.75e-05	3	153	2	10213508
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR2 RYR3	5.75e-05	3	153	2	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR2 RYR3	5.75e-05	3	153	2	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR2 RYR3	5.75e-05	3	153	2	7635066
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-7 ERVK-10 ERVK-5 ERVK-24 ERVFRD-1	6.18e-05	94	153	5	21542922
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	OGT MRPS27 MRPL13 RPS18 MDN1 MRPS34 CNOT1	6.77e-05	226	153	7	25900982
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	FLII COL5A2 SLITRK4 MRPS27 RYR3 DIP2A MDN1 CNOT1 ANO3 HYDIN	7.54e-05	497	153	10	36774506
Pubmed	Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.	DNAH1 LMAN2L GAL3ST3 FUT1 FER1L5	9.12e-05	102	153	5	21926972
Pubmed	The TSC-mTOR signaling pathway regulates the innate inflammatory response.	MTOR PRKCQ	1.15e-04	4	153	2	18848473
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR2 RYR3	1.15e-04	4	153	2	23413940
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR2 RYR3	1.15e-04	4	153	2	9607712
Pubmed	Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice.	LPA SERPINE1	1.15e-04	4	153	2	28270519
Pubmed	CD4 raft association and signaling regulate molecular clustering at the immunological synapse site.	PTPRC PRKCQ	1.15e-04	4	153	2	15128768
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR2 RYR3	1.15e-04	4	153	2	23482488
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR2 RYR3	1.15e-04	4	153	2	18206662
Pubmed	Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.	LPA SERPINE1	1.15e-04	4	153	2	12070304
Pubmed	Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer.	TRAF2 MTOR	1.15e-04	4	153	2	25738361
Pubmed	Nucleoredoxin negatively regulates Toll-like receptor 4 signaling via recruitment of flightless-I to myeloid differentiation primary response gene (88).	FLII NXN	1.15e-04	4	153	2	20400501
Pubmed	Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.	LPA SERPINE1	1.15e-04	4	153	2	28336948
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR2 RYR3	1.15e-04	4	153	2	9384575
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-10 ERVK-5	1.15e-04	4	153	2	7983737
Pubmed	Elevation of hsa-miR-7-5p level mediated by CtBP1-p300-AP1 complex targets ATXN1 to trigger NF-κB-dependent inflammation response.	PDZD9 UBA3 MED24 DIP2A CES3 CES4A	1.15e-04	171	153	6	36629882
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	AMPD3 TRAF2 METRNL TMC6 SLITRK4 PFKFB4 SULT1C4 NXN FBXO47 IDO2 DIP2A MDN1 SGMS1 MTOR GLO1 ILDR1	1.24e-04	1242	153	16	30973865
Pubmed	A large set of estrogen receptor β-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cell nuclei.	MRPS27 RPS18 ZC3HAV1	1.79e-04	25	153	3	21182203
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	CACNA2D1 TMEM120B EFCAB6 SLC15A2 DOCK7 MOB3B PRKCQ	1.81e-04	265	153	7	19240061
Pubmed	Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.	LPA SERPINE1	1.91e-04	5	153	2	11557572
Pubmed	Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.	LPA SERPINE1	1.91e-04	5	153	2	18957535
Pubmed	Fibrinolytic crosstalk with endothelial cells expands murine mesenchymal stromal cells.	LPA SERPINE1	1.91e-04	5	153	2	27283026
Pubmed	Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis.	LPA SERPINE1	1.91e-04	5	153	2	17656680
Pubmed	Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.	PTPRC LTA	1.91e-04	5	153	2	10067894
Pubmed	Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.	ERVK-7 ERVK-5	1.91e-04	5	153	2	11401426
Pubmed	MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.	MAN2B1 SOX8	1.91e-04	5	153	2	23739915
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR2 RYR3	1.91e-04	5	153	2	23918386
Pubmed	Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.	LPA SERPINE1	1.91e-04	5	153	2	17431190
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR2 RYR3	1.91e-04	5	153	2	19011160
Pubmed	ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5.	TRAF2 LTA	1.91e-04	5	153	2	9153189
Pubmed	The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.	LPA SERPINE1	1.91e-04	5	153	2	11818362
Pubmed	Mammalian carboxylesterase 3: comparative genomics and proteomics.	CES3 CES4A	1.91e-04	5	153	2	20422440
Pubmed	Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.	RYR2 RYR3	1.91e-04	5	153	2	33060591
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	CACNA2D1 EFCAB6 WRN GAS7 CNKSR2 SLFN5 POGLUT1 MDN1 FAM107A MTOR LTA WDR17 PLK4 ANO3 HYDIN DUSP11	1.96e-04	1293	153	16	15342556
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	DYNC2H1 MRPL13 MTOR FGFR1 CNOT1 SDK1 TOP2B CNTN1	1.98e-04	358	153	8	32460013
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	RYR2 RYR3	2.85e-04	6	153	2	19549818
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR2 RYR3	2.85e-04	6	153	2	23463619
Pubmed	A mammalian protein kinase with potential for serine/threonine and tyrosine phosphorylation is related to cell cycle regulators.	AOX1 FGFR1	2.85e-04	6	153	2	1825055
Interaction	TSPY8 interactions	TSPY3 TSPY2 TSPY8	3.73e-07	3	146	3	int:TSPY8
Cytoband	Yp11.2	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 TSPY10	3.19e-08	94	153	7	Yp11.2
Cytoband	Ensembl 112 genes in cytogenetic band chrYp11	TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 TSPY10	7.85e-07	150	153	7	chrYp11
Cytoband	3q13.33	POGLUT1 SLC15A2 ILDR1	1.38e-04	30	153	3	3q13.33
Cytoband	4q21.23	COQ2 WDFY3	8.40e-04	13	153	2	4q21.23
Cytoband	3p21.3	RTP3 SLC22A13 DLEC1	1.03e-03	59	153	3	3p21.3
Cytoband	10q26.11	SFXN4 INPP5F	1.28e-03	16	153	2	10q26.11
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	1.04e-04	3	107	2	287
GeneFamily	Carboxylesterases	CES3 CES4A	3.43e-04	5	107	2	461
GeneFamily	Ferlin family	OTOF FER1L5	5.12e-04	6	107	2	828
GeneFamily	Mitochondrial ribosomal proteins	MRPS27 MRPL13 MRPL39 MRPS34	1.24e-03	79	107	4	646
GeneFamily	Anoctamins	ANO6 ANO3	1.51e-03	10	107	2	865
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	RYK FGFR1 MUSK	1.70e-03	40	107	3	321
GeneFamily	Sterile alpha motif domain containing	CNKSR2 SFMBT2 SGMS1 USH1G	1.85e-03	88	107	4	760
GeneFamily	Dyneins, axonemal	DNAH1 DNAH8	4.45e-03	17	107	2	536
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PARP4 ZC3HAV1	4.45e-03	17	107	2	684
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 CNKSR2 GALNT13 RYR2 RYR3 DNAH1 SDK1 ANO3 HYDIN CNTN1	6.84e-10	184	149	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 CNKSR2 GALNT13 RYR2 RYR3 DNAH1 SDK1 ANO3 HYDIN CNTN1	6.84e-10	184	149	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 CNKSR2 GALNT13 RYR2 RYR3 DNAH1 SDK1 ANO3 HYDIN CNTN1	6.84e-10	184	149	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL5A2 CACNA2D1 AOX1 RYR2 MAMDC2 SERPINE1 SDK1 MUSK	2.61e-07	190	149	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	control-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	OGT SLFN5 SFMBT2 PARP4 PTPRC SGMS1 PRKCQ CD96	2.94e-07	193	149	8	89d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL5A2 AOX1 GAS7 RYR2 SERPINE1 MOB3B SDK1	3.63e-06	190	149	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 AOX1 RYR2 MAMDC2 SDK1 ANO3 MUSK	3.75e-06	191	149	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 AOX1 RYR2 MAMDC2 SDK1 ANO3 MUSK	3.89e-06	192	149	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 AOX1 RYR2 MAMDC2 SDK1 MUSK	4.02e-06	193	149	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 AOX1 RYR2 MAMDC2 SDK1 MUSK	4.16e-06	194	149	7	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 GAS7 CNKSR2 RYR2 SDK1 CNTN1	4.16e-06	194	149	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL5A2 DYNC2H1 GAS7 NXN MAMDC2 SERPINE1 MUSK	4.30e-06	195	149	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	COL5A2 AOX1 RYR2 MAMDC2 SDK1 ANO3 MUSK	4.30e-06	195	149	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	AMPD3 CD300A TMC6 SFMBT2 GPR160 FAM78A PTPRC	5.08e-06	200	149	7	26251ed8c7fa7e87973d6f59bd398c88ad025395
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A2 GALNT13 RYR2 RYR3 WDR17 HYDIN	1.66e-05	160	149	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A2 GALNT13 RYR2 RYR3 WDR17 HYDIN	1.66e-05	160	149	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma-7\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	TSPY4 TSPY2 TSPY9 TSPY8 TSPY10	2.07e-05	99	149	5	4f0346fe85ba006d1ab28a61624568522ffe5cb4
ToppCell	droplet-Kidney-nan-24m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	METRNL CD300A PFKFB4 PTPRC OTOF MUSK	2.12e-05	167	149	6	2ee1660be117e20f24557522345572d11cbee813
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BEST1 CD300A FAM78A PTPRC FZD5 RUFY4	2.26e-05	169	149	6	15a9183c838cc6384d7f5dfeae3d30602964c9b3
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AMPD3 TRAF2 NPR3 TMEM101 OTOF PLK4	2.58e-05	173	149	6	12f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCell	facs-SCAT-Fat-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRC FZD5 CES4A ILDR1 PRKCQ CD96	2.67e-05	174	149	6	87fa5deff5c1aabb342d674f05ad17c4c0e50d01
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	CACNA2D1 GPRC5A NXN GALNT13 SLC15A2 ANO6	3.76e-05	185	149	6	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	Control-T_cells-CD8+_T_cells\|Control / group, cell type (main and fine annotations)	SFMBT2 DIP2A PTPRC PRKCQ CD96 ZC3HAV1	3.76e-05	185	149	6	02ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL5A2 AOX1 RYR2 MAMDC2 SERPINE1 MUSK	3.87e-05	186	149	6	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NXN CHST15 SERPINE1 SDK1 ANO3 CNTN1	3.99e-05	187	149	6	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	COL5A2 RYR2 MAMDC2 SDK1 ANO3 MUSK	3.99e-05	187	149	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	OGT SLFN5 DIP2A PRKCQ CD96 ZC3HAV1	4.23e-05	189	149	6	e9df7ecd36bee1fedce23bb188c68a94fa60462c
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PATL2 SLFN5 DIP2A PTPRC PRKCQ CD96	4.36e-05	190	149	6	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL5A2 DYNC2H1 AOX1 GAS7 MAMDC2 MUSK	4.49e-05	191	149	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CD300A SFMBT2 DIP2A PTPRC PRKCQ CD96	4.49e-05	191	149	6	6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e
ToppCell	COPD-Lymphoid-T\|World / Disease state, Lineage and Cell class	OGT RYR2 PTPRC PRKCQ CD96 ZC3HAV1	4.62e-05	192	149	6	eb4909574fb5fc91399463523e2737095773200a
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	COL5A2 DYNC2H1 AOX1 GAS7 MAMDC2 MUSK	4.62e-05	192	149	6	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	COL5A2 DYNC2H1 AOX1 GAS7 MAMDC2 MUSK	4.76e-05	193	149	6	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 GAS7 CNKSR2 RYR2 SDK1	4.76e-05	193	149	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	COL5A2 CACNA2D1 GAS7 RYR2 SERPINE1 MUSK	4.90e-05	194	149	6	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CD300A GAS7 SFMBT2 FAM78A PTPRC CD96	5.04e-05	195	149	6	2d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	PATL2 ADGRL1 SLFN5 DIP2A PTPRC CD96	5.04e-05	195	149	6	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	COPD-Lymphoid-T\|COPD / Disease state, Lineage and Cell class	OGT RYR2 PTPRC PRKCQ CD96 ZC3HAV1	5.18e-05	196	149	6	30e53b8050d2a041f855d0e39bbd8f923c64c489
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	GAS7 CNKSR2 GALNT13 MAMDC2 SERPINE1 LRRC15	5.18e-05	196	149	6	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PATL2 ADGRL1 SLFN5 DIP2A PTPRC CD96	5.18e-05	196	149	6	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PATL2 ADGRL1 SLFN5 DIP2A PTPRC CD96	5.18e-05	196	149	6	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 AOX1 RYR2 MAMDC2 SDK1	5.18e-05	196	149	6	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PATL2 ADGRL1 SLFN5 DIP2A PTPRC CD96	5.18e-05	196	149	6	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PATL2 ADGRL1 SLFN5 DIP2A PTPRC CD96	5.18e-05	196	149	6	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 AOX1 RYR2 MAMDC2 SDK1 MUSK	5.18e-05	196	149	6	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	PATL2 SLFN5 DIP2A PTPRC PRKCQ CD96	5.33e-05	197	149	6	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|lung / Disease (COVID-19 only), tissue and cell type	CD300A GAS7 PFKFB4 PTPRC CHST15 OTOF	5.33e-05	197	149	6	a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCell	COVID_vent-Lymphocytic-T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	RPS18 SLFN5 PTPRC PRKCQ CD96 ZC3HAV1	5.33e-05	197	149	6	ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PATL2 SLFN5 DIP2A PTPRC PRKCQ CD96	5.33e-05	197	149	6	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL5A2 DYNC2H1 CNKSR2 RYR2 RYR3 MUSK	5.48e-05	198	149	6	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 IPO7 MDN1 SERPINE1 FGFR1 ANO3	5.48e-05	198	149	6	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAN2B1 CD300A PFKFB4 FAM78A PTPRC RUFY4	5.48e-05	198	149	6	0b928a829844f49f4d47e88908af192cb919011f
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL5A2 CACNA2D1 AOX1 RYR2 MAMDC2 SDK1	5.48e-05	198	149	6	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL5A2 AOX1 RYR2 MAMDC2 SDK1 MUSK	5.48e-05	198	149	6	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	METRNL CD300A PTPRC LTA PRKCQ CD96	5.64e-05	199	149	6	713fab2e946b300d21215aff1553785e8857ce65
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD3\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CD300A FAM78A PTPRC LTA PRKCQ CD96	5.64e-05	199	149	6	4be4527f351b701438a8bcb738229a06dbf8bc96
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-CD4_T\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SLFN5 PTPRC LTA PRKCQ CD96 ZC3HAV1	5.64e-05	199	149	6	992bc4f0dc4189f18773c55976eb124c3827e08b
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CD300A FAM78A PTPRC LTA PRKCQ CD96	5.64e-05	199	149	6	d3dc52e1f0040763888f951a7c047db4a329a653
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLITRK4 SOX8 GALNT13 FGFR1 HYDIN CNTN1	5.64e-05	199	149	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	distal-Hematologic-Intermediate_Monocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	METRNL CD300A GAS7 SFMBT2 PTPRC CHST15	5.64e-05	199	149	6	f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e
ToppCell	distal-Hematologic-Intermediate_Monocyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	METRNL CD300A GAS7 SFMBT2 PTPRC CHST15	5.64e-05	199	149	6	fa362f3e456a4853652e52d54e76473809eea76d
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL5A2 AOX1 RYR2 SERPINE1 SDK1 LRRC15	5.64e-05	199	149	6	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	METRNL CD300A PTPRC LTA PRKCQ CD96	5.64e-05	199	149	6	ffd5b4d58d81b76e01d87016209f16879d81c592
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 AOX1 GAS7 RYR2 FGFR1 SDK1	5.80e-05	200	149	6	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RPS18 SLFN5 PTPRC LTA PRKCQ CD96	5.80e-05	200	149	6	3154d5c4fef8848473f5317606f860549a92c23c
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 AOX1 GAS7 RYR2 MAMDC2 SDK1	5.80e-05	200	149	6	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 AOX1 GAS7 RYR2 MAMDC2 SDK1	5.80e-05	200	149	6	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	AMPD3 CD300A TMC6 SFMBT2 FAM78A PTPRC	5.80e-05	200	149	6	16caefcc5bdca82d904462c6fd0ffa80d96fa474
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PATL2 SFMBT2 PTPRC PRKCQ CD96 ZC3HAV1	5.80e-05	200	149	6	893bb7c25ad7c6589a4c7c0364c2ace666e9b4be
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A2 AOX1 GAS7 RYR2 MAMDC2 SDK1	5.80e-05	200	149	6	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	PATL2 SLFN5 FAM78A DIP2A PTPRC CD96	5.80e-05	200	149	6	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	LPS-IL1RA-Endothelial-Epi-like-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EFCAB6 HEATR4 LMAN2L SLC15A2 FER1L5	1.01e-04	138	149	5	5f8ac8f67e34a7cf560099208e6884102532391e
ToppCell	Control-Neu_1\|Control / 5 Neutrophil clusters in COVID-19 patients	CANX PARP4 CHST15	1.10e-04	28	149	3	eb8d8303c1a8f8f8cf9f8c2180406c06624690af
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PATL2 FAM78A PTPRC PRKCQ CD96	1.28e-04	145	149	5	a9f5a32abcf3eb2c66bd65f2521a6dd4ce56c635
ToppCell	droplet-Lung-nan-3m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2B1 METRNL CD300A GAS7 SLFN5	1.32e-04	146	149	5	ed932d43e9efd064ee4b49ddef529f3d041be765
ToppCell	droplet-Lung-nan-3m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2B1 METRNL CD300A GAS7 SLFN5	1.32e-04	146	149	5	0d74962779055c774312d59fc3b1365163741c3a
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PATL2 FAM78A PTPRC PRKCQ CD96	1.45e-04	149	149	5	4fda987bc7bb6d1dbd41b8f1f8c1bc59613255a8
ToppCell	PBMC-Severe-cDC_1\|Severe / Compartment, Disease Groups and Clusters	NXN OTOF FGFR1 WDR17	1.58e-04	81	149	4	6d1e524f000b71c935359afc801a1d31f218fec8
ToppCell	droplet-Fat-SCAT-30m-Myeloid-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	METRNL CD300A PTPRC ANO3 KNL1	1.64e-04	153	149	5	2731c3d4ac40ecc22108f8f3f45a069077159125
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PDZD9 NXN MTOR SDK1 LRRC15	1.80e-04	156	149	5	6c8f442ed94ae31e6832b68137e98ae78091ac6c
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NPR3 HTR6 CNKSR2 SFMBT2 RTP3	1.85e-04	157	149	5	1f21d78a467fe22c5ab75d0917b840c1ac93f32c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 BEST1 CHST15 LPA CNTN1	1.96e-04	159	149	5	330ecbba97d47bc818a5e8d1d84b05d056bd831e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 SLFN5 TEDDM1 ANO3 CNTN1	1.96e-04	159	149	5	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 BEST1 CHST15 LPA CNTN1	1.96e-04	159	149	5	cbb331eb689d8cea9e1146ba85e0a05d23301c47
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRL1 SLFN5 FZD5 PRKCQ CD96	2.02e-04	160	149	5	55f599df6e3b7a5a505df4b094c834281311d94a
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRL1 SLFN5 FZD5 PRKCQ CD96	2.02e-04	160	149	5	296e53e1e0786346d38db2d4188b9a1c0430627b
ToppCell	Globus_pallidus-Neuronal-Excitatory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CACNA2D1 CNKSR2 RYR3 OTOF ANO3	2.02e-04	160	149	5	f843287ed57d2d5a3b3f6dfb03b6934e330e6645
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM107A SLC15A2 REEP6 SLC22A13 CA5A	2.14e-04	162	149	5	de0fde4310a56dc96bfc134c44d104993526d9bc
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC15A2 MTOR SLC22A13 TGM7 CA5A	2.14e-04	162	149	5	6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLFN5 SFMBT2 PTPRC CD96 ZC3HAV1	2.20e-04	163	149	5	11cc18f36604d9a5f4e7fb8626a8f0fb141da5e1
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SFMBT2 SLC22A13 TGM7 PRKCQ	2.27e-04	89	149	4	eda156a61e7d14087cfdae5e733d6862834fb0e5
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PATL2 MAN2B1 WRN PTPRC OTOF	2.27e-04	164	149	5	30c3c25b05a403a509b2e755c2f0878fecb10a02
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Myeloid\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	METRNL CD300A GAS7 PTPRC MOB3B	2.33e-04	165	149	5	518ee34c18065100a2f2c6e407d3a7866b908593
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Myeloid-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	METRNL CD300A GAS7 PTPRC MOB3B	2.33e-04	165	149	5	becb8f726b84509ec29c75b530a3fe757651301d
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV5/7_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD300A SLFN5 PTPRC PRKCQ CD96	2.33e-04	165	149	5	207f9ca8839f54710e2112986def4bc7b0ef1a28
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	METRNL CD300A GAS7 PTPRC MOB3B	2.33e-04	165	149	5	ae8dd9c00f96590f27ed21cd6314f4577e00e312
ToppCell	facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM78A PTPRC PRKCQ CD96 ZC3HAV1	2.40e-04	166	149	5	3695407e4638f3c18fbff63daba52baa9256c429
ToppCell	droplet-Heart-nan-24m-Hematologic-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2B1 METRNL CD300A PFKFB4 PTPRC	2.54e-04	168	149	5	0ef2d8dbcccc812dd0d99769048b95cf06faf023
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM107A SLC15A2 REEP6 SLC22A13 CA5A	2.54e-04	168	149	5	b14fd50232887b6dca1f39014d43c6f66e5c3b5c
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC15A2 MTOR SLC22A13 TGM7 CA5A	2.54e-04	168	149	5	35ce3b2b9c9997d4c101da5949c7271d6a6b8f12
Drug	LI-W	WRN ADGRL1 LRRC15	9.66e-07	4	143	3	CID015991564
Drug	chloro-m-cresol	CACNA2D1 RYR2 RYR3	4.79e-06	6	143	3	CID000012008
Drug	Azumoleno	CACNA2D1 RYR2 RYR3	8.34e-06	7	143	3	CID000056259
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	BEST1 DOCK7 MUSK	3.66e-05	14	140	3	OBA_2045100
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	6.68e-05	3	140	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	6.68e-05	3	140	2	DOID:8545 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (16:0_18:2) in blood serum	BEST1 DOCK7 MUSK	1.12e-04	20	140	3	OBA_2045071
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	BEST1 DOCK7 MUSK	1.31e-04	21	140	3	OBA_2045156
Disease	bone disease (implicated_via_orthology)	NPR3 FGFR1	2.21e-04	5	140	2	DOID:0080001 (implicated_via_orthology)
Disease	stimulant use measurement	RYK NBAS DLEC1	3.14e-04	28	140	3	EFO_0600076
Disease	level of Phosphatidylinositol (18:1_18:2) in blood serum	DOCK7 MUSK	3.31e-04	6	140	2	OBA_2045160
Disease	1-stearoyl-2-linoleoyl-GPC (18:0/18:2) measurement	DOCK7 MUSK	3.31e-04	6	140	2	EFO_0800404
Disease	1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement	DOCK7 MUSK	4.62e-04	7	140	2	EFO_0800609
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	OTOF FER1L5	4.62e-04	7	140	2	DOID:11724 (implicated_via_orthology)
Disease	octadecanedioylcarnitine (C18-DC) measurement	CYP4V2 HEATR4	4.62e-04	7	140	2	EFO_0800371
Disease	lysophosphatidylcholine 20:4 measurement	CACNA2D1 BEST1 MUSK	4.69e-04	32	140	3	EFO_0010363
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	BEST1 LPA DOCK7 MUSK	5.27e-04	78	140	4	EFO_0022187
Disease	1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement	DOCK7 MUSK	6.14e-04	8	140	2	EFO_0800610
Disease	1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement	DOCK7 MUSK	6.14e-04	8	140	2	EFO_0800396
Disease	level of Phosphatidylinositol (16:0_18:2) in blood serum	DOCK7 MUSK	6.14e-04	8	140	2	OBA_2045153
Disease	nitric oxide exhalation measurement	PRDM12 DLEC1 ANO3	7.81e-04	38	140	3	EFO_0005536
Disease	1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement	DOCK7 MUSK	7.87e-04	9	140	2	EFO_0800439
Disease	1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement	DOCK7 MUSK	7.87e-04	9	140	2	EFO_0800412
Disease	sleep duration, low density lipoprotein cholesterol measurement	METRNL LPA DOCK7 MUSK	9.42e-04	91	140	4	EFO_0004611, EFO_0005271
Disease	sex interaction measurement, longitudinal BMI measurement	WRN MOB3B	9.81e-04	10	140	2	EFO_0005937, EFO_0008343
Disease	1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement	DOCK7 MUSK	9.81e-04	10	140	2	EFO_0800469
Disease	level of Phosphatidylcholine (16:0_20:3) in blood serum	DOCK7 MUSK	9.81e-04	10	140	2	OBA_2045075
Disease	cholesteryl esters to total lipids in small LDL percentage	LPA DOCK7 MUSK	1.05e-03	42	140	3	EFO_0022255
Disease	childhood onset asthma	MED24 PTPRC GAL3ST3 ILDR1 LTA PRKCQ FGFR1	1.11e-03	334	140	7	MONDO_0005405
Disease	free cholesterol to total lipids in IDL percentage	LPA DOCK7 MUSK	1.12e-03	43	140	3	EFO_0022278
Disease	lysophosphatidylcholine 20:2 measurement	BEST1 MUSK	1.20e-03	11	140	2	EFO_0021458
Disease	myocardial infarction (is_implicated_in)	WRN LPA SERPINE1 LTA	1.29e-03	99	140	4	DOID:5844 (is_implicated_in)
Disease	level of Phosphatidylinositol (16:0_18:1) in blood serum	DOCK7 MUSK	1.43e-03	12	140	2	OBA_2045152
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	DOCK7 MUSK	1.43e-03	12	140	2	OBA_2045157
Disease	cholesteryl ester 20:2 measurement	BEST1 MUSK	1.43e-03	12	140	2	EFO_0021440
Disease	mortality	SOX8 NXN SFMBT2 MAMDC2 MOB3B	1.44e-03	173	140	5	EFO_0004352
Disease	total lipids in lipoprotein particles measurement	LPA DOCK7 FUT1	1.55e-03	48	140	3	EFO_0022309
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK7 MUSK	1.68e-03	13	140	2	OBA_2045159
Disease	1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement	DOCK7 MUSK	1.68e-03	13	140	2	EFO_0800413
Disease	phosphatidylcholine ether measurement	BEST1 MUSK	1.68e-03	13	140	2	EFO_0010227
Disease	polyunsaturated fatty acids to total fatty acids percentage	LPA DOCK7 MUSK	1.74e-03	50	140	3	EFO_0022303
Disease	diabetic retinopathy (is_implicated_in)	GLO1 SERPINE1 LTA	1.74e-03	50	140	3	DOID:8947 (is_implicated_in)
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	BEST1 LPA DOCK7	1.84e-03	51	140	3	EFO_0022302
Disease	diglyceride measurement	BEST1 SHFL MUSK	1.84e-03	51	140	3	EFO_0010223
Disease	1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement	DOCK7 MUSK	1.96e-03	14	140	2	EFO_0022085
Disease	caudate volume change measurement	CNKSR2 GALNT13	1.96e-03	14	140	2	EFO_0021491
Disease	level of Phosphatidylcholine (18:1_20:2) in blood serum	BEST1 MUSK	1.96e-03	14	140	2	OBA_2045102
Disease	level of Phosphatidylethanolamine (18:2_0:0) in blood serum	BEST1 MUSK	1.96e-03	14	140	2	OBA_2045143
Disease	vascular dementia (biomarker_via_orthology)	MTOR FGFR1	1.96e-03	14	140	2	DOID:8725 (biomarker_via_orthology)
Disease	pulmonary hypertension (implicated_via_orthology)	MTOR SERPINE1 FGFR1	2.17e-03	54	140	3	DOID:6432 (implicated_via_orthology)
Disease	triglycerides in large VLDL measurement	LPA DOCK7 MUSK	2.41e-03	56	140	3	EFO_0022178
Disease	cholesteryl esters to total lipids in medium HDL percentage	LPA DOCK7 MUSK	2.41e-03	56	140	3	EFO_0022251
Disease	teratocarcinoma-derived growth factor 1 measurement	GAS7 RTP3	2.57e-03	16	140	2	EFO_0008297
Disease	1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement	DOCK7 MUSK	2.57e-03	16	140	2	EFO_0800184
Disease	vision disorder	SDK1 CNTN1	2.57e-03	16	140	2	MONDO_0021084
Disease	level of Phosphatidylcholine (18:0_18:2) in blood serum	DOCK7 MUSK	2.57e-03	16	140	2	OBA_2045090
Disease	ankle brachial index	NBAS LPA	2.57e-03	16	140	2	EFO_0003912
Disease	lymphocyte:monocyte ratio	TRAF2 METRNL COQ2 LTA VARS1 KNL1	2.59e-03	288	140	6	EFO_0600088
Disease	triglycerides in VLDL measurement	LPA DOCK7 MUSK	2.80e-03	59	140	3	EFO_0022326
Disease	free cholesterol in very large VLDL measurement	LPA DOCK7 MUSK	3.08e-03	61	140	3	EFO_0022274
Disease	triglycerides in medium LDL measurement	LPA DOCK7 MUSK	3.22e-03	62	140	3	EFO_0022322
Disease	total lipids in very large VLDL measurement	LPA DOCK7 MUSK	3.22e-03	62	140	3	EFO_0022313
Disease	free cholesterol in very large HDL measurement	LPA DOCK7 MUSK	3.22e-03	62	140	3	EFO_0022273
Disease	phospholipids in very large VLDL measurement	LPA DOCK7 MUSK	3.22e-03	62	140	3	EFO_0022299
Disease	lysophosphatidylcholine 22:6 measurement	CACNA2D1 MUSK	3.25e-03	18	140	2	EFO_0010365
Disease	level of Phosphatidylcholine (20:4_0:0) in blood serum	BEST1 MUSK	3.25e-03	18	140	2	OBA_2045110
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	DOCK7 MUSK	3.25e-03	18	140	2	OBA_2045155
Disease	level of Phosphatidylcholine (15:0_18:2) in blood serum	DOCK7 MUSK	3.25e-03	18	140	2	OBA_2045065
Disease	esterified cholesterol measurement	BEST1 LPA DOCK7 MUSK	3.29e-03	128	140	4	EFO_0008589
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	DYNC2H1 LPA SERPINE1	3.37e-03	63	140	3	EFO_0001645, EFO_0004792
Disease	diacylglycerol 38:3 measurement	BEST1 MUSK	3.63e-03	19	140	2	EFO_0020065
Disease	cholesterol in very large VLDL measurement	LPA DOCK7 MUSK	3.68e-03	65	140	3	EFO_0022230
Disease	total lipids in large VLDL	LPA DOCK7 MUSK	4.01e-03	67	140	3	EFO_0022175
Disease	exercise test	WRN RYR2	4.02e-03	20	140	2	EFO_0004328
Disease	end stage renal disease (implicated_via_orthology)	MTOR SERPINE1	4.02e-03	20	140	2	DOID:783 (implicated_via_orthology)
Disease	free cholesterol in large VLDL measurement	LPA DOCK7 MUSK	4.18e-03	68	140	3	EFO_0022265
Disease	susceptibility to mononucleosis measurement	RYR2 MDN1 DNAH8	4.36e-03	69	140	3	EFO_0008403
Disease	level of Phosphatidylcholine (18:1_20:4) in blood serum	BEST1 MUSK	4.42e-03	21	140	2	OBA_2045104
Disease	level of Phosphatidylcholine (16:0_20:4) in blood serum	BEST1 MUSK	4.42e-03	21	140	2	OBA_2045076
Disease	level of Phosphatidylcholine (16:1_18:2) in blood serum	BEST1 MUSK	4.42e-03	21	140	2	OBA_2045083

Protein segments in the cluster

Peptide	Gene	Start	Entry
YANPKEWGRAPLRDM	USH1G	261	Q495M9
PPAMLNALYGRWVLA	HTR6	81	P50406
KPPMFGDYEAQRHWQ	ALG6	31	Q9Y672
DPLQAGDRIYVMPWI	ADGRL1	166	O94910
QYENLPWPDRLMSLV	BEST1	96	O76090
LNQMPLYPTEKIIWD	AQR	421	O60306
MIYPLDLFRNIPWKQ	LINC01600	1	Q96MT4
SINPKKLVMGVPWYG	CTBS	241	Q01459
NPGIAWKYALPKVMN	ADAMTS18	851	Q8TE60
KVYSPNMRWIIQVPR	AMPD3	461	Q01432
LKQIWNNFMELGYPL	ANO3	701	Q9BYT9
RFEMRPNVKYPWGPL	NPR3	441	P17342
KMIPRDEPGSYVPWN	AOX1	1321	Q06278
MAPKVFRQYWDIPDG	NDUFA11	1	Q86Y39
WLLTKQRNPMDYPVE	GPRC5A	266	Q8NFJ5
MARPEYREWNPELIK	FAM107A	16	O95990
MPSNKDYVVRPKWNV	IWS1	756	Q96ST2
EGPGWTRVKVKPNMY	MAMDC2	356	Q7Z304
ALPAPQYMNLLMDWI	MOB3B	111	Q86TA1
TPRWEQDYHLQPMGK	ANO6	646	Q4KMQ2
EMVINVRDYPQVPKW	POGLUT1	126	Q8NBL1
LAIGGNPEPSLMWYK	NPHS1	466	O60500
PLMKRISYWPQLALG	COQ2	196	Q96H96
IRMDNPFYPRWLEKE	PRKCQ	591	Q04759
YWLMWNPLPGMQQRE	MDN1	3031	Q9NU22
LVMPPKPADRAAEWY	FLII	376	Q13045
EAPYRNMLPAGNPWL	HSFY1	356	Q96LI6
RGGYILPWQEPAMNT	MGAM2	1666	Q2M2H8
VWLGPKYMRNKQPFS	ELOVL5	46	Q9NYP7
YKMPCGQWLPIDLQN	KIAA2026	1066	Q5HYC2
YNWPEMKLFVAGGPL	DCAF12L2	436	Q5VW00
DHYRPWMEIANKLPQ	IDO2	51	Q6ZQW0
KNMITQYWPDRETAP	IPO7	61	O95373
DPDGYWIEILNPNKM	GLO1	166	Q04760
VRAPSPYWIMVKQDN	PDZD9	216	Q8IXQ8
PLKKIWMPYSNGRPA	PFKFB4	11	Q16877
WLLPYIMKFPLNRQA	CES4A	356	Q5XG92
MPPIAGKILWVRQLY	DNAH8	511	Q96JB1
AQALGPQMMGKPLYW	ILDR1	226	Q86SU0
LKRWGPNYNLMNIDI	KNL1	2246	Q8NG31
AIWYTKDRMQPGPVF	LMAN2L	131	Q9H0V9
WYQQPPGTAPKLMIY	IGLV2-18	56	A0A075B6J9
EWMYPTGALIVNLRP	METRNL	81	Q641Q3
IPVMKVYNPARGEWR	KBTBD7	531	Q8WVZ9
PANRYTPLKENWMKI	PNO1	81	Q9NRX1
MIPPDQELLVWYGNS	PRDM12	191	Q9H4Q4
MQRKGPPQRWCLQVY	ERVK-5	6	P61583
MQRKGPPRRWCLQVY	ERVK-7	6	P61582
LPYMSWQGEPQEAVR	PARP4	1206	Q9UKK3
LVLLLQAWPPMKSEY	NBAS	2176	A2RRP1
WKRNPLPKNAENMYY	OSBP	681	P22059
ICNPLRYPNIMTWKV	OR2D2	126	Q9H210
EQWPRKLYMQLIPQQ	PTOV1	296	Q86YD1
KLNFRWYPVPQREMD	GALNT13	261	Q8IUC8
KVQIPAYIEMNIPWL	GPR160	266	Q9UJ42
MQRKGPPRRWCLQVY	ERVK-24	6	P61581
KKPWSQQPDPYANLM	PATL2	176	C9JE40
PRPWNGALMLYQRVV	REEP6	126	Q96HR9
YRPLQPLMNRKVWAS	CA5A	281	P35218
TGQPRAKPEYWVLML	FZD5	491	Q13467
WQPSRKVDIMGYDLP	GAL3ST3	356	Q96A11
EPINLQWVMAKYPVL	DNAH1	4001	Q9P2D7
PDMQRGLDYFKPWLS	DYNC2H1	2266	Q8NCM8
LMYWDRKQGVQLPPA	HYDIN	2471	Q4G0P3
PVGYTWIPMLQNGRL	DOCK7	666	Q96N67
RWKDYLPVGQRMPGT	DUSP11	81	O75319
WNEMPVNAKGRLKYP	EFCAB6	1221	Q5THR3
RPWYIQGAASPKDML	CACNA2D1	241	P54289
TDNTKPNRMPVAPYW	FGFR1	141	P11362
PFPVYKWRMNNGDVD	CNTN1	71	Q12860
YQSLPPRLGWGMILN	HEATR4	16	Q86WZ0
PMIDNPSYQGIWKPR	CANX	386	P27824
DINGPWCYTMNPRKL	LPA	1776	P08519
QMYLNRDIWKPAPCQ	COL5A2	46	P05997
KLWVGPVPMVALYNA	CYP4V2	91	Q6ZWL3
QVIVYNPLGRKVNWM	MAN2B1	511	O00754
LKPWPMVNQARLLYI	FBXO47	241	Q5MNV8
YNWPEMKLFVAGGPL	DCAF12L1	436	Q5VU92
PYALMKANPLSWIQK	DIP2A	581	Q14689
AWRYQLLPKMEIGPV	ELP4	161	Q96EB1
DLWPFYPRNGVMTKD	FKRP	416	Q9H9S5
PVPRAGQKFREAWMQ	CES3	531	Q6UWW8
FYWQIMKPNLQPLMP	DLEC1	646	Q9Y238
MGWEYPENRLPSLKN	SLC22A13	111	Q9Y226
MGVPLPTLQWYKDAI	SDK1	411	Q7Z5N4
YIPLPMFWALLDQQG	SLC15A2	306	Q16348
QPLPVKCNRIYQIMW	INPP5F	491	Q9Y2H2
LPYMNWGNLKLFLRQ	RYK	411	P34925
DPAIRWQMALYKDLP	RYR2	3521	Q92736
IPVMKVYNPVRAEWR	KBTBD6	531	Q86V97
HGYNIWRDPMKPSQI	OTOF	1601	Q9HC10
FALRPAPIQAMWLGY	OGT	651	O15294
PALRHLYKELMGPWN	SERPINE1	96	P05121
TQREPKEMQKPQWYR	MTOR	221	P42345
RGDYLQVMPQRWKGV	FUT1	221	P19526
NMPLIWKPGYLDRAL	MRPS27	246	Q92552
LNVQRIRMEPWDYPA	MRPS34	191	P82930
KGLLPNVLKPGWMQY	RTP3	31	Q9BQQ7
EPLLRPQWYVRCGEM	VARS1	671	P26640
LLPLKAWLENMPYNI	SLITRK4	221	Q8IW52
ALVDGQPWDMYKPLT	MRPL39	106	Q9NYK5
IPQFVQMKYGLTGPW	SFXN4	181	Q6P4A7
WYIPIIPMVLINGAE	TOP2B	861	Q02880
GVMLTWPNGPIYQKF	TMEM120B	201	A0PK00
RKQVPSRFMYPKEWQ	TEDDM1	56	Q5T9Z0
DAQVLMWRPKYGQPL	FAM78A	261	Q5JUQ0
WLYRLNTVLPEPQMG	FER1L5	681	A0AVI2
PMPNLRELWLYDNHI	LRRC15	291	Q8TF66
WHQQQPGKAPRYLMK	IGLV4-60	56	A0A075B6I1
QDFVRDMPWLALPYK	NXN	101	Q6DKJ4
WFPASYVQLLEKPGM	GAS7	51	O60861
GVDTMPYWNLLPPKR	MED24	691	O75448
YPQSMWEPEGKELQL	RUFY4	261	Q6ZNE9
PVRGLMWNTEIPYLL	WDR17	611	Q8IZU2
FDMEWPPLYNRGKLG	WRN	81	Q14191
LKGYDWSLVPMPVRG	SOX8	76	P57073
MQRKGPPRRWCLQVY	ERVK-10	6	P61580
MEPPWGYQNRTLRSI	PLK4	576	O00444
YANLELLMWPLQEKP	CD300A	231	Q9UGN4
GPMWPITQKILRDFY	CHST15	526	Q7LFX5
KLRPISMPVEYNWVG	CNKSR2	436	Q8WXI2
PQQKGWPMYAQLLID	CNOT1	2056	A5YKK6
RKRYEPVPADKMWGL	SHFL	136	Q9NUL5
FVVMKGPNDALLRWP	TRAF2	411	Q12933
EYVRMLQWPKEQPFG	UBA3	251	Q8TBC4
LWRNPLQYYKRMKPP	TSPY9	286	A0A494C1R9
WRNPLQYYKRMKPPE	TSPY10	281	P0CW01
WRNPLQYYKRMKPPE	TSPY2	281	A6NKD2
SQKMVYPGLQEPWLH	LTA	151	P01374
LWRNPLQYYKRMKPP	TSPY4	286	P0CV99
YRMRQLGYPPGWLKE	ZCCHC8	311	Q6NZY4
WRNPLQYYKRMKPPE	TSPY1	281	Q01534
PYNLPWRKSAGEVLM	WDFY3	226	Q8IZQ1
RKWCQYQKEIMERPP	CD96	541	P40200
YRWDPNLKGLMRPAN	ERVFRD-1	76	P60508
MLLAKGYPDVGWNPI	RYR3	2176	Q15413
RMNKALPAPGTWEEY	SULT1C4	151	O75897
RPVGWCQENKYRMDP	SFMBT2	241	Q5VUG0
PELERSQYPMEWGKT	SGMS1	121	Q86VZ5
RKEPLAVVGSPYWMA	TESK1	211	Q15569
MQNPRQYKIPDWFLN	RPS18	71	P62269
RIWYLLDGKMQPPGK	MRPL13	16	Q9BYD1
WRNPLQYYKRMKPPE	TSPY3	281	P0CV98
WRNPLQYYKRMKPPE	TSPY8	281	P0CW00
ALMPWRYALKRIGGQ	TMC6	226	Q7Z403
RRPTFVPQWYVQQMK	ZC3HAV1	681	Q7Z2W4
NECWMIRKDLPPGYN	TGM7	341	Q96PF1
YWKPEVMIAAQGPLK	PTPRC	1026	P08575
SLVMLYEPKWAQGVP	SLFN5	741	Q08AF3
RVYKGIPMNIRGPVW	USP6	96	P35125
HWRQMIYAPKKTVPQ	ZNF891	171	A8MT65
LPPVMLLIDGNVAYW	TMEM101	211	Q96IK0
QVALHIYPMNPEIWK	TTC33	151	Q6PID6
YKANENDAIPIRWMP	MUSK	756	O15146